MedPath

Effects of serial whole body cryotherapy on disease activity, functional health, cytokines and marker of bone and cartilage metabolism in rheumatoid diseases, e.g, rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis and primary fibromyalgia, and healthy individuals

Not Applicable
Completed
Conditions
M06.80
M05.8
M45.0
L40.5
M79
Other seropositive rheumatoid arthritis
Arthropathic psoriasis
Other soft tissue disorders, not elsewhere classified
Registration Number
DRKS00021218
Lead Sponsor
Campus Kerckhoff der Justus-Liebig-Universität Gießen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
192
Inclusion Criteria

confirmed rheumatoid arthritis according to the ACR/EULAR classification criteria of rheumatoid arthritis of 2010
- confirmed psoriatic arthritis according to the CASPAR criteria
- confirmed axial spondylarthritis / ankylosing arthritis according to the ASAS classification criteria
- confirmed primary fibromyalgia according to the ACR/EULAR criteria of 2010 and the modification of 2011
- Health control subjects after medical examination
- Written consent and approval of the study
- stable medication (antirheumatic as well as analgesic and other basic medication) 4 weeks before starting the study and during the entire study

Exclusion Criteria

Contraindications for whole-body cold therapy treatment (cryoglobulins, cold urticaria, vasculitis, Raynaud's syndrome, unstable arterial hypertension, peripheral arterial circulatory disorders, cold hypersensitivity, disturbed temperature sensation, bladder and kidney diseases, etc.) .
No written consent.
No comprehension of the study.
Lack of German knowledge.
Presence of an accompanying secondary pain syndrome in patients with inflammatory rheumatic diseases (RA, PsA, axSpA)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.